Fludarabine
Specifications
21679-14-1CAS Number
244-525-5EC Number
(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diolIUPAC Name
C10H12FN5O4Chemical Formula
285.23 g/molMolecular Weight
Fludarabine; 21679-14-1; F-Ara-A; 2-Fluoro Ara-A; Fludarabina; Fluradosa; 9-beta-D-Arabinofuranosyl-2-fluoroadenine; Fludarabinum; 2-F-ARAA; 2-fluorovidarabine; DTXSID4039657; (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; CCRIS 3382; 2-Fluoro-9-beta-D-arabinofuranosyladenine; 9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine; P2K93U8740; 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro-; DTXCID2019657; 2-Fluoroadenine arabinoside; NSC118218; RefChem:58475; L01BB05; 2-Fluoro-9-beta-arabinofuranosyladenine; 244-525-5; (((2R,3S,4S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)phosphonic acid; (2R,3S,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Fludarabine [INN]; 9-b-d-arabinofuranosyl-2-fluoroadenine; MFCD00132942; 2-F-ara-A; Fludarabine (INN); (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; Fludarabine Phosphate EP Impurity E; NSC 118218; MLS000028687; 9-ss-D-Arabinofuranosyl-2-fluoroadenine; SMR000058874; Fludarabinum [Latin]; Fludarabina [Spanish]; FaraA; Fludarabine (Fludara); Fluradosa (TN); CAS-21679-14-1; 2-FLUORO-9-ARABINOADENINE; 2F-Ara-A; F-ara-A;NSC 118218; Fludarabine?; UNII-P2K93U8740; HSDB 6964; NCGC00181336-01; EINECS 244-525-5; NSC 118218H; Fludarabine free base; Fludarabine (Standard); FLUDARABINE [MI]; 2-Fluoroadenine Arabinosid; Adenine, 9-beta-D-arabinofuranosyl-2-fluoro-; FLUDARABINE [HSDB]; FLUDARABINE [VANDF]; SCHEMBL3510; CHEMBL1568; FLUDARABINE [WHO-DD]; 9-?-D-Arabinofuranosyl-2-fluoro-9H-purin-6-amine; MLS006011578; cid_657237; GTPL4802; orb1225653; orb1309978; SCHEMBL29371011; BDBM68391; CHEBI:94701; HY-B0069R; EX-A833; GLXC-04596; HMS2232K13; HMS3259F09; HMS3413N14; HMS3677N14; HMS3715F15; HY-B0069; NSC-118218H; Tox21_112795; Tox21_113419; EBC-11027; HG1007; AKOS015854911; AKOS015916481; Tox21_113419_1; CCG-221147; DB01073; DS-1271; NC00633; NF05140; NCGC00021920-04; NCGC00021920-07; NCGC00181336-03; NCGC00182047-03; BP-25389; BP-55389; SY067428; 2-Fluoro-9-(b-D-arabinofuranosyl)adenine; F0658; F4781; NS00003718; EN300-52641; C21550; D07966; AB00383071-11; AB00383071_13; F079410; SR-01000000270; 2-FLUORO-9-.BETA.-D-ARABINOFURANOSYLADENINE; 9-.BETA.-D-ARABINOFURANOSYL-2-FLUOROADENINE; 9-b-D-Arabinofuranosyl-2-fluoro-9H-purin-6-amine; 9-ss-D-Arabinofuranosyl-2-fluoro-9H-purin-6-amine; SR-01000000270-2; BRD-K66788707-001-14-3; FLUDARABINE PHOSPHATE IMPURITY E [EP IMPURITY]; Z756440078; 9-.BETA.-D-ARABINOFURANOSYL-2-FLUORO-9H-PURIN-6-AMINE; FLUDARABINE PHOSPHATE IMPURITY, 2-FLUORO-ARA-ADENINE- [USP IMPURITY]; (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol; (2R,3S,4S,5R)-2-(6-amino-2-fluoro-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; (2R,3S,4S,5R)-2-(6-amino-2-fluoro-purin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; (2R,3S,4S,5R)-2-(6-azanyl-2-fluoranyl-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 2-Fluoroadenine-9-beta-D-arabinofuranoside, DNA synthesis and methylation inhibitor; (2R,3S,4S,5R)-2-(6-Amino-2-fluoro -9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diolSynonyms